Ali A Alshamrani

12PUBLICATIONS
30CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersNanomaterialsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 26, 2026
Development and Evaluation of Physiologically Based Pharmacokinetic (PBPK) Models of Metoclopramide Across the Lifespan: Translation from Adults to Infants.

|Aug 29, 2024
Genetic and Epigenetic Biomarkers Associated with Early Relapse in Pediatric Acute Lymphoblastic Leukemia: A Focused Bioinformatics Study on DNA-Repair Genes.

Walaa F Albaqami, Ali A Alshamrani, Ali A Almubarak

|Feb 24, 2024
Synthesis, Characterization, and Toxicity Assessment of Zinc Oxide-Doped Manganese Oxide Nanoparticles in a Macrophage Model.

Nasser B Alsaleh, Anas M Aljarbou, Mohamed E Assal

|Nov 25, 2023
Dapagliflozin Mitigated Elevated Disomic and Diploid Sperm in a Mouse Model of Diabetes and Recover the Disrupted Ogg1, Parp1, and P53 Gene Expression.

Norah A Albekairi, Mohammed A Al-Hamamah, Ali A Alshamrani

|Oct 28, 2023
Impacts of the DPP-4 Inhibitor Saxagliptin and SGLT-2 Inhibitor Dapagliflozin on the Gonads of Diabetic Mice.

Ali A Alshamrani, Mohammed A Al-Hamamah, Norah A Albekairi

|Sep 09, 2023
Vincristine-Induced Neuropathy in Patients Diagnosed with Solid and Hematological Malignancies: The Role of Dose Rounding.

Abdulrahman M Alwhaibi, Ali A Alshamrani, Miteb A Alenazi

Pageof 2

Frequent Collaborators

4 joint publications

Ahmed Nadeem

4 joint publications

Sheikh F Ahmad

3 joint publications

Homood M As Sobeai

3 joint publications

Mohammed A Assiri